Carregant...
Combination Therapy Against Indian Visceral Leishmaniasis with Liposomal Amphotericin B (Fungisome(TM)) and Short-Course Miltefosine in Comparison to Miltefosine Monotherapy
Visceral leishmaniasis (VL) is endemic in Asia, East and North Africa, South America, and Southern Europe, and is a major public health problem in the Indian subcontinent. Miltefosine received approval in 2002 to treat VL in India, and the Indian National Vector Borne Disease Control Programme later...
Guardat en:
| Publicat a: | Am J Trop Med Hyg |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The American Society of Tropical Medicine and Hygiene
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356435/ https://ncbi.nlm.nih.gov/pubmed/32394874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.19-0931 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|